泰林生物 (300813.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(泰林生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 60,631,217.0563,539,832.1878,946,553.19140,162,721.9388,015,314.6474,165,319.5071,534,758.17
 营业收入(元) 60,631,217.0563,539,832.1878,946,553.19140,162,721.9388,015,314.6474,165,319.5071,534,758.17
二、营业总成本(元) 67,901,429.0560,477,377.9864,924,390.99119,002,980.4274,896,193.6761,612,916.7956,632,371.43
 营业成本(元) 29,943,672.7925,732,042.4937,718,346.7774,096,976.5741,863,294.2930,301,162.2031,009,277.47
 研发费用(元) 17,557,580.9316,626,043.6413,945,439.8419,424,392.0516,051,887.7215,290,344.0113,701,030.39
 营业税金及附加(元) 665,609.33717,966.78744,630.781,723,967.43553,773.55529,671.81552,750.48
 销售费用(元) 12,892,064.5910,396,962.677,383,430.2515,714,072.1110,764,615.598,620,628.197,818,019.22
 管理费用(元) 9,741,842.448,698,233.588,098,391.5110,418,430.268,051,932.158,386,144.636,220,370.82
 财务费用(元) -2,899,341.03-1,693,871.18-2,965,848.16-2,374,858.00-2,389,309.63-1,515,034.05-2,669,076.95
  其中:利息费用(元) 188,502.60173,334.859,908.47406,866.92---
  其中:利息收入(元) -12,841,233.048,065,851.12-3,080,935.2917,009,784.31-11,493,091.167,150,208.84-2,752,973.34
 资产减值损失(元) -38,101.12---647,852.89182,579.74--
 信用减值损失(元) -292,573.83479,583.54-176,430.03334,849.89-252,676.351,660,285.50-323,417.79
三、其他经营收益
 加:投资收益(元) ---88,767.12-156,680.72115,240.60
 资产处置收益(元) ---2,158.20-26,345.82---
 其他收益(元) 6,110,102.842,707,215.444,217,745.679,195,334.983,082,189.104,354,518.35105,289.96
四、营业利润(元) -1,490,784.116,123,086.3718,061,319.6430,104,494.7916,131,213.4618,577,345.4314,799,499.51
 加:营业外收入(元) 174,484.49533,585.2798,698.951,344,242.6336,290.98-26,471.5792,574.53
 减:营业外支出(元) 583,945.81-2,465.9340,275.781,092,200.7817,443.08704.491,530.69
五、利润总额(元) -1,900,245.436,659,137.5718,119,742.8130,356,536.6416,150,061.3618,550,169.3714,890,543.35
 减:所得税费用(元) 340,671.891,227,551.50544,717.22-2,069,671.52188,869.541,176,545.89965,364.27
六、净利润(元) -2,240,917.325,431,586.0717,575,025.5932,426,208.1615,961,191.8217,373,623.4813,925,179.08
(一)按经营持续性分类
  持续经营净利润(元) -2,240,917.325,431,586.0717,575,025.5932,426,208.1615,961,191.8217,373,623.4813,925,179.08
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -1,882,070.905,618,997.1217,575,025.5932,426,208.1615,961,191.8217,373,623.4813,925,179.08
  少数股东损益(元) -358,846.42------
 扣除非经常性损益后的净利润(元) -3,356,942.374,254,145.2916,037,503.3830,352,551.2015,079,756.4613,602,731.4413,681,580.11
七、每股收益
 一、基本每股收益(元) -0.01-0.210.390.190.110.27
 二、稀释每股收益(元) -0.01-0.200.370.190.090.27
九、综合收益总额(元) -2,240,917.325,431,586.0717,575,025.5932,426,208.1615,961,191.8217,373,623.4813,925,179.08
 归属于母公司所有者的综合收益总额(元) -1,882,070.905,618,997.1217,575,025.5932,426,208.1615,961,191.8217,373,623.4813,925,179.08
 归属于少数股东的综合收益总额(元) -358,846.42------
公告日期 2023-10-272023-08-302023-04-272023-04-042022-10-272022-08-292022-04-29
审计意见(境内) 标准无保留意见

前瞻产业研究院